3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Alzheimer Disease
2
Stress Disorders, Post-Traumatic
1
Sleep Initiation and Maintenance Disorders
1
Sleep Disorders, Circadian Rhythm
1
Sleep Deprivation
1
REM Sleep Behavior Disorder
1
Psychological Well-Being
1
Pain
1
Otolaryngeal Cancer
1
Neoplasm Metastasis
1
Lymphoma, Follicular
1
Idiopathic Hypersomnia
1
Depression
1
Dementia
1
Combat Disorders
1
Cognitive Dysfunction
1
Chronobiology Disorders
1
Cancer Pain
1
Breast Neoplasms
1
Anxiety Disorders
1
Agnosia
1
Interventions
Morphine
15
Oxycodone
13
Fentanyl
9
nabiximols
5
Methadone
5
Lidocaine
5
Acetaminophen
5
resiniferatoxin
4
Ethanol
4
Acupuncture Therapy
4
Transcutaneous Electric Nerve Stimulation
3
Hydromorphone
3
Transcranial Direct Current Stimulation
2
Surveys and Questionnaires
2
Standard of Care
2
Sodium Bicarbonate
2
Radiofrequency Ablation
2
Pharmaceutical Services
2
Naloxone
2
Ketamine
2
Electroacupuncture
2
Dronabinol
2
Control Groups
2
Buprenorphine
2
Analgesics, Opioid
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
tanezumab
1
rofecoxib
1
naloxegol
1
incobotulinumtoxinA
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Cancer Pain
×
Electroencephalography
×
Clear all
NCT06644573
2025-05-28
PSHW
PROSOMNIA Sleep Health & Wellness
Phase 1
Not yet recruiting
100 enrolled